4.6 Article

Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

期刊

BRITISH JOURNAL OF SPORTS MEDICINE
卷 56, 期 20, 页码 1157-1170

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/bjsports-2021-105132

关键词

-

资金

  1. European Union [634935, 633784]
  2. PERSPECTIVE I&I project by the Government of Canada through Genome Canada
  3. Canadian Institutes of Health Research
  4. Ministere de l'Economie et de l'Innovation du Quebec through Genome Quebec
  5. Quebec Breast Cancer Foundation
  6. National Cancer Institute Intramural Research Program, National Institutes of Health
  7. NIH [U19 CA148065, CA58860, CA92044]
  8. Cancer Research UK Grant [C1287/A16563, C490/A10124, C490/A16561]
  9. PERSPECTIVE project - Government of Canada through Genome Canada
  10. Canadian Institutes of Health Research [GPH-129344]
  11. Ministere de l'Economie, Science et Innovation du Quebec through Genome Quebec
  12. European Community [223175 (HEALTH-F2-2009-223175)]
  13. Cancer Research UK [C1287/A10118, C1287/A10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565, C1275/A11699, C1275/C22524, C1275/A19187, C1275/A15956]
  14. National Institutes of Health [CA128978]
  15. Post-Cancer GWAS initiative [1U19 CA148537, 1U19 CA148065, 1U19 CA148112]
  16. Department of Defence [W81XWH-10-1-0341]
  17. Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer
  18. Komen Foundation for the Cure
  19. Breast Cancer Research Foundation
  20. Ovarian Cancer Research Fund
  21. Wellcome Trust [v203477/Z/16/Z]
  22. National Cancer Institute (USA) [UM1 CA164920]
  23. National Health and Medical Research Council of Australia
  24. New South Wales Cancer Council
  25. Victorian Health Promotion Foundation (Australia)
  26. Victorian Breast Cancer Research Consortium
  27. Dutch Cancer Society [NKI 2007-3839, 2009 4363, RUL 1997-1505, DDHK 2004-3124, DDHK 2009-4318]
  28. The Cancer Institute NSW
  29. National Breast Cancer Foundation
  30. intramural research program of the National Institutes of Health
  31. National Cancer Institute [UM1 CA164920, Z01-CP010119, P50 CA058223, U54 CA156733, U01 CA179715]
  32. National Institute of Environmental Health Sciences [Z01-ES049030]
  33. ELANFond of the University Hospital of Erlangen
  34. Cancer Research UK
  35. Breast Cancer Now
  36. NHS
  37. National Health and Medical Research Council, Australia
  38. Cancer Council Western Australia
  39. Breast Cancer Research Foundation (BCRF)
  40. Accion Estrategica de Salud del Instituto de Salud Carlos III [FIS PI12/02125]
  41. FEDER [PI17/00918]
  42. Accion Estrategica de Salud del Instituto de Salud Carlos III FIS Intrasalud [PI13/01136]
  43. Programa Grupos Emergentes, Cancer Genetics Unit, Instituto de Investigacion Biomedica Galicia Sur. Xerencia de Xestion Integrada de Vigo-SERGAS, Instituto de Salud Carlos III, Spain
  44. Conselleria de Industria Programa Sectorial de Investigacion Aplicada, PEME I + D e I + D Suma del Plan Gallego de Investigacion, Desarrollo e Innovacion Tecnologica de la Conselleria de Industria de la Xunta de Galicia, Spain [10CSA012E]
  45. Fomento de la Investigacion Clinica Independiente, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain [EC11-192]
  46. FEDERInnterconecta. Ministerio de Economia y Competitividad, Xunta de Galicia, Spain
  47. Dietmar-Hopp Foundation
  48. Helmholtz Society
  49. German Cancer Research Center (DKFZ)
  50. Canadian Cancer Society [313404]
  51. University of Crete
  52. Fondation de France
  53. Institut National du Cancer (INCa)
  54. Ligue Nationale contre le Cancer
  55. Agence Nationale de Securite Sanitaire, de l'Alimentation, de l'Environnement et du Travail (ANSES)
  56. Agence Nationale de la Recherche (ANR)
  57. Chief Physician Johan Boserup and Lise Boserup Fund
  58. Danish Medical Research Council
  59. Herlev and Gentofte Hospital
  60. The American Cancer Society
  61. National Cancer Institute of the National Institutes of Health [U01-CA199277, P30-CA033572, P30-CA023100, UM1-CA164917, R01-CA077398]
  62. California Department of Public Health [103885]
  63. Centers for Disease Control and Prevention [5NU58DP006344]
  64. National Cancer Institute's Surveillance, Epidemiology and End Results Program [HHSN261201800032I]
  65. Against Breast Cancer Registered Charity [1121258]
  66. NCRN
  67. European Commission (DG-SANCO)
  68. International Agency for Research on Cancer
  69. Ligue Contre le Cancer (France)
  70. Institut Gustave Roussy (France)
  71. Mutuelle Generale de l'Education Nationale (France)
  72. Institut National de la Sante et de la Recherche Medicale (INSERM) (France)
  73. German Cancer Aid (Germany)
  74. German Cancer Research Center (DKFZ) (Germany)
  75. Federal Ministry of Education and Research (BMBF) (Germany)
  76. Hellenic Health Foundation (Greece)
  77. Stavros Niarchos Foundation (Greece)
  78. Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy (Italy)
  79. National Research Council (Italy)
  80. Dutch Ministry of Public Health, Welfare and Sports (VWS) (The Netherlands)
  81. Netherlands Cancer Registry (NKR) (The Netherlands)
  82. LK Research Funds (The Netherlands)
  83. Dutch Prevention Funds (The Netherlands)
  84. Dutch ZON (Zorg Onderzoek Nederland) (The Netherlands)
  85. World Cancer Research Fund (WCRF) (The Netherlands)
  86. Statistics Netherlands (The Netherlands)
  87. Health Research Fund (FIS) (Spain) [PI13/00061, PI13/01162]
  88. Regional Government of Andalucia (Spain)
  89. Regional Government of Asturias (Spain)
  90. Regional Government of Basque Country (Spain)
  91. Regional Government of Murcia (Spain)
  92. Regional Government of Navarra (Spain)
  93. ISCIII RETIC (Spain) [RD06/0020]
  94. Cancer Research UK (United Kingdom) [14136, C570/A16491, C8221/A19170]
  95. Medical Research Council (United Kingdom) [1000143, MR/M012190/1]
  96. Baden Wurttemberg Ministry of Science, Research and Arts
  97. German Cancer Aid (Deutsche Krebshilfe)
  98. NIHR [PGfAR 0707-10031]
  99. NIHR Manchester Biomedical Research Centre [IS-BRC1215-20007]
  100. German Cancer Aid [110837, 70114178]
  101. Federal Ministry of Education and Research, Germany [01GY1901]
  102. European Regional Development Fund
  103. Free State of Saxony, Germany [713-241202, 14505/2470, 14575/2470]
  104. Federal Ministry of Education and Research (BMBF) Germany [01KW9975/5, 01KW9976/8, 01KW9977/0, 01KW0114, 01KH0402]
  105. Robert Bosch Foundation, Stuttgart
  106. Deutsches Krebsforschungszentrum (DKFZ), Heidelberg
  107. Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum
  108. Department of Internal Medicine, Johanniter GmbH Bonn, Johanniter Krankenhaus, Bonn, Germany
  109. Deutsche Krebshilfe e. V. [70492, 70-2892-BR I, 106332, 108253, 108419, 110826, 110828]
  110. Claudia von Schilling Foundation for Breast Cancer Research
  111. Lower Saxonian Cancer Society
  112. Rudolf Bartling Foundation
  113. Helsinki University Hospital Research Fund
  114. Sigrid Juselius Foundation
  115. Cancer Foundation Finland
  116. Friends of Hannover Medical School
  117. German Federal Ministry of Research and Education [RUS08/017]
  118. Russian Foundation for Basic Research [17-44-020498, 17-29-06014]
  119. Ministry of Science and Higher Education of the Russian Federation [AAAA-A16-116020350032-1]
  120. KARBAC
  121. Stockholm County Council
  122. Karolinska Institutet
  123. The Gustav V Jubilee foundation
  124. Bert von Kantzows foundation
  125. Marit and Hans Rausings Initiative Against Breast Cancer
  126. special Government Funding (VTR) of Kuopio University Hospital grants
  127. Cancer Fund of North Savo
  128. Finnish Cancer Organizations
  129. University of Eastern Finland
  130. Stichting tegen Kanker
  131. FWO
  132. Research Centre for Genetic Engineering and Biotechnology Georgi D. Efremov, MASA
  133. Hamburg Cancer Society
  134. Italian Association for Cancer Research (AIRC)
  135. NIH grants [U19 CA148065, R01CA100374, R35CA253187, R01CA192393, R01CA116167, R01CA176785, CA63464, CA54281, CA098758, CA132839, CA164973, CA97396, CA128931, CA116201, CA140286, CA177150, P01 CA87969, UM1 CA186107, UM1 CA176726]
  136. NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer [P50CA116201]
  137. VicHealth
  138. Cancer Council Victoria
  139. Australian National Health and Medical Research Council [209057, 396414, 1074383]
  140. Swedish Cancer Society
  141. Swedish Research Council
  142. Local hospital funds
  143. Berta Kamprad Foundation
  144. Robert and Kate Niehaus Clinical Cancer Genetics Initiative
  145. Canadian Institutes of Health Research for the CIHR Team in Familial Risks of Breast Cancer program [CRN-87521]
  146. Ministry of Economic Development, Innovation and Export Trade [PSR-SIIRI-701]
  147. K.G. Jebsen Centre for Breast Cancer Research
  148. Research Council of Norway [193387/V50, 193387/H10]
  149. South Eastern Norway Health Authority [39346]
  150. Norwegian Cancer Society
  151. USA National Cancer Institute of the National Institutes of Health [U01CA164920]
  152. Komen Foundation
  153. North Carolina University Cancer Research Fund
  154. Biobanking and Biomolecular Resources Research Infrastructure [BBMRI-NL CP16]
  155. Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA
  156. Intramural Research Program of the National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics
  157. Intramural Research Program of the Division of Cancer Epidemiology and Genetics
  158. Division of Cancer Prevention, National Cancer Institute, National Institutes of Health
  159. Breast Cancer Campaign [2010PR62, 2013PR044]
  160. Sheffield Experimental Cancer Medicine Centre
  161. Breast Cancer Now Tissue Bank
  162. UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge
  163. Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [Z01-ES049033, Z01-ES044005, Z01-ES102245]
  164. Susan G. Komen for the Cure [FAS0703856]
  165. DKFZ
  166. Swedish Cancer Foundation
  167. Swedish Research Council [VR 2017-00644]
  168. program of the Minister of Science and Higher Education [002/RID/2018/19]
  169. Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]
  170. National Cancer Institute (NCI) grant [R01 CA163353]
  171. Women's Cancer Center at the Huntsman Cancer Institute (HCI)
  172. Utah Population Database (UPDB)
  173. Utah Cancer Registry (UCR)
  174. HCI (Huntsman Cancer Foundation)
  175. University of Utah program in Personalized Health and Center for Clinical and Translational Science
  176. NCI [P30 CA42014]
  177. NCI's SEER Program [HHSN261201800016I]
  178. US Center for Disease Control and Prevention's National Program of Cancer Registries [NU58DP0063200]
  179. University of Utah
  180. Huntsman Cancer Foundation
  181. Lon V Smith Foundation [LVS39420]
  182. Institute of Cancer Research (ICR), London
  183. The Eve Appeal (The Oak Foundation)
  184. National Institute for Health Research University College London Hospitals Biomedical Research Centre
  185. National Institute for Health Research [NIHR202411]
  186. Cancer Research UK programme grant (the Integrative Cancer Epidemiology Programme) [C18281/A19169]
  187. NIHR Bristol Biomedical Research Centre - NIHR
  188. Medical Research Council [MC_UU_00011/1, MC_UU_00011/3, MC_UU_00011/6, MC_UU_00011/4]
  189. University of Bristol
  190. Victorian Cancer Agency [MCRF-18005]
  191. [PSRSIIRI-701]
  192. [HHSN261201800015I]
  193. [HHSN261201800009I]
  194. [ERC-2011-294576]
  195. [P30 CA68485]
  196. [PBZ_KBN_122/P05/2004]

向作者/读者索取更多资源

The study provides strong evidence that higher overall physical activity, greater vigorous activity, and lower sedentary time are likely to reduce the risk of breast cancer. The adoption of active lifestyles may help reduce the burden of the most common cancer in women.
Objectives Physical inactivity and sedentary behaviour are associated with higher breast cancer risk in observational studies, but ascribing causality is difficult. Mendelian randomisation (MR) assesses causality by simulating randomised trial groups using genotype. We assessed whether lifelong physical activity or sedentary time, assessed using genotype, may be causally associated with breast cancer risk overall, pre/post-menopause, and by case-groups defined by tumour characteristics. Methods We performed two-sample inverse-variance-weighted MR using individual-level Breast Cancer Association Consortium case-control data from 130 957 European-ancestry women (69 838 invasive cases), and published UK Biobank data (n=91 105-377 234). Genetic instruments were single nucleotide polymorphisms (SNPs) associated in UK Biobank with wrist-worn accelerometer-measured overall physical activity (n(snps)=5) or sedentary time (n(snps)=6), or accelerometer-measured (n(snps)=1) or self-reported (n(snps)=5) vigorous physical activity. Results Greater genetically-predicted overall activity was associated with lower breast cancer overall risk (OR=0.59; 95% confidence interval (CI) 0.42 to 0.83 per-standard deviation (SD;similar to 8 milligravities acceleration)) and for most case-groups. Genetically-predicted vigorous activity was associated with lower risk of pre/perimenopausal breast cancer (OR=0.62; 95% CI 0.45 to 0.87,>= 3 vs. 0 self-reported days/week), with consistent estimates for most case-groups. Greater genetically-predicted sedentary time was associated with higher hormone-receptor-negative tumour risk (OR=1.77; 95% CI 1.07 to 2.92 per-SD (similar to 7% time spent sedentary)), with elevated estimates for most case-groups. Results were robust to sensitivity analyses examining pleiotropy (including weighted-median-MR, MR-Egger). Conclusion Our study provides strong evidence that greater overall physical activity, greater vigorous activity, and lower sedentary time are likely to reduce breast cancer risk. More widespread adoption of active lifestyles may reduce the burden from the most common cancer in women.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据